Formulations of anti-viral compounds
A pharmaceutical composition comprising a compound of Formula (I) or a pharmaceutically acceptable salt thereof; wherein X is selected from a hydroxyl, a metal salt hydroxylate, an O-linked phosphoester, an O-linked phosphoramidite, an O-linked ester, an O-linked carbamate, an S-linked phosphothioat...
Saved in:
Main Authors | , , , , |
---|---|
Format | Patent |
Language | English |
Published |
13.04.2023
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Summary: | A pharmaceutical composition comprising a compound of Formula (I) or a pharmaceutically acceptable salt thereof; wherein X is selected from a hydroxyl, a metal salt hydroxylate, an O-linked phosphoester, an O-linked phosphoramidite, an O-linked ester, an O-linked carbamate, an S-linked phosphothioate, or an N-linked phosphoramidite, and at least one pharmaceutically acceptable excipient selected from a cysteine compound, an amino acid, an |
---|---|
Bibliography: | Application Number: AU20210334028 |